Condition

Autoimmune

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common interventions5

Lead sponsors shown2

Clinical trials

3 shown

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid ArthritisNCT05697159 · 2023-08-22

RECRUITING

Use of Stromal Vascular Fraction in Multiple SclerosisNCT03461419 · 2019-08-01

SUSPENDED

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic ConditionsNCT02939859 · 2018-12-15

WITHDRAWN

Common interventions

Centricyte 1000DEVICE2 Microcannula Harvest AdiposePROCEDURE1 Microcannula Harvest Adipose StromaPROCEDURE1 Sterile Normal Saline IV deployment AD-cSVFPROCEDURE1 Sterile Normal Saline IV Deployment of cSVFPROCEDURE1

Leading sponsors

Healeon Medical Inc 2 NHS Greater Glasgow and Clyde 1

Trial status mix

RECRUITING1

SUSPENDED1

WITHDRAWN1

Phase mix

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.